Serum thioredoxin and α-tocopherol concentrations in patients with major risk factors

Circulation Journal

Volumn 69, Issue 3, 2005, Pages 291-294

  Miwa, Kunihisa ^a   Kishimoto, Chiharu ^b   Nakamura, Hajime ^c   Makita, Tbshinori ^d   Ishii, Katsuhisa ^d   Okuda, Nobuaki ^d   Yodoi, Junji ^c   Sasayama, Shigetake ^a  

^a HAMAMATSU ROSAI HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KANSAI ELECTRIC POWER CO   (Japan)

Author keywords

Tocopherol; Coronary risk factors; Oxidative stress; Thioredoxin

Indexed keywords

ALPHA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOREDOXIN; TRIACYLGLYCEROL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; OXIDATIVE STRESS; RISK FACTOR; SMOKING;

ADULT; AGED; ALPHA-TOCOPHEROL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; SMOKING; THIOREDOXIN;

EID: 15744377143     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.291     Document Type: Article

References (28)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modification of low-density lipoprotein in atherogenicity. N Engl J Med 1989; 320: 915-924.
2. Miwa K, Miyagi Y, Fujita M. Susceptibility of plasma low-density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol 1995; 26: 632-638.
3. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E deficiency in variant angina. Circulation 1996; 94: 14-18.
4. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-79.
5. Yasue H, Takizawa A, Nagao M, Nishida S, Kubota J, Omote S, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
6. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoking extract contracts isolated coronary porcine arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994; 266: H874-H880.
7. Morrow JD, Frai B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-1203.
8. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppänen R, Kantola M, et al. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 1988; 48: 1226-1232.
9. Tesfamariam B, Cohen RA. Role of superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am J Physiol 1992; 262: H1915-H1919.
10. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.
11. Lacy F, O'Connor DT, Schmid-Schönbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291-303.
12. Inoue N, Ohara Y, Fukai T, Harrison DG, Nishida K. Probucol improves endothelium-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. Am J Med Sci 1998; 315: 242-247.
13. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36: 142-146.
14. Laurent TC, Moore EC, Reichard P. Enzymatic synthesis of deoxyribonucleotides: IV: Isolation and characterization of thioredoxin, the hydrogen donor from escherichia coli. J Biol Chem 1964; 239: 3436-3444.
15. Hayashi T, Ueno Y, Okamoto T. Oxidireductive regulation of nuclear factor kappa-B involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 1993; 268: 11380-11388.
16. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997; 15: 351-369.
17. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264: 13963-13966.
18. Ericson M L, Horling J, Wendel HV, Holmgren A, Rosen A. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res 1992; 11: 201-207.
19. Nakamura H, DeRosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996; 8: 603-611.
20. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 2000; 33: 616-622.
21. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 2001; 65: 491-494.
22. Shioji K, Matsuura Y, Iwase T, Kitaguchi S, Nakamura H, Yodoi J, et al. Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: A case report. Circ J 2002; 66: 977-980.
23. Miyamoto M, Kishimoto C, Shioji K, Lee JD, Shimizu H, Ueda T, et al. Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ J 2003; 67: 116-118.
24. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 2003; 26: 177-181.
25. Friedwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-508.
26. Nakamura H, Vaage J, Valen G, Padilla CA, Björnstedt M, Holmgren A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic Biol Med 1998; 24: 1176-1186.
27. Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan K, et al. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leucocyte chemotaxis in mice. Circulation 2004; 110: 1276-1283.
28. Miwa K, Okinaga S, Fujita M. Low serum α-tocopherol concentrations in subjects with various coronary risk factors. Circ J 2004; 68: 542-546.